论文部分内容阅读
为了加强对移植中成药品种的管理,卫生部曾于一九八八年下发了“关于恢复中成药移植问题的通知”,要求各地按照通知精神,对中成药移植的品种认真审查,严格把关,防止出现新的混乱。经过一年多的实践,该措施对保护制药企业的利益,促进开发新药,起到了积极作用。但是,仍有一些地区存在各种问题,为了纠正这些问题,加强中成药移植的管理,最近,卫生部发出了“关于加强中成药移植品种管理的通知”。通知中规定:
In order to strengthen the management of transplanted proprietary Chinese medicines, the Ministry of Health issued a “Circular on Recovering Traditional Chinese Medicines Transplantation” in 1988, and requested all localities to carefully review the varieties of proprietary Chinese medicines transplanted in accordance with the spirit of the notification and strictly monitor To prevent new confusion. After more than a year of practice, this measure has played a positive role in protecting the interests of pharmaceutical companies and promoting the development of new drugs. However, there are still problems in some areas. In order to correct these problems, the management of proprietary Chinese medicine transplants has been strengthened. Recently, the Ministry of Health issued the “Notice on Strengthening the Management of Chinese Traditional Medicine Transplant Species”. The notice states: